Our results demonstrated that caprylic triglyceride alleviates ALS-type motor impairment through restoration of energy metabolism in SOD1-G93A ALS mice, especially during the overt stage of the disease. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.